KEYFORM-008: Coformulated favezelimab and pembrolizumab (MK4280A) versus chemotherapy in relapsed/refractory classical Hodgkin lymphoma.

Basit Öğe Kaydı
dc.authorid0000-0001-9636-4113
dc.contributor.authorLavie, David
dc.contributor.authorTimmerman, John
dc.contributor.authorSanz, Ramon Garcia
dc.contributor.authorKim, Won Seog
dc.contributor.authorKim, Tae Min
dc.contributor.authorAvigdor, Abraham
dc.contributor.authorDierickx, Daan
dc.contributor.authorJagadeesh, Deepa
dc.contributor.authorHerrera, Alex Francisco
dc.date.accessioned2024-01-25T12:04:07Z
dc.date.available2024-01-25T12:04:07Z
dc.date.issued2023
dc.departmentİstanbul Medipol Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, İç Hastalıkları Ana Bilim Dalı
dc.description.abstract[Abstract Not Available]
dc.description.sponsorshipMerck Sharp Dohme LLCen_US
dc.identifier.citationLavie, D., Timmerman, J., Sanz, R. G., Kim, W.S., Kim, T. M., Avigdor, A. ... Herrera, A. F. (2023). KEYFORM-008: Coformulated favezelimab and pembrolizumab (MK4280A) versus chemotherapy in relapsed/refractory classical Hodgkin lymphoma. Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO). Chicago, IL, 02-06 June, 2023.
dc.identifier.issn0732-183X
dc.identifier.issn1527-7755
dc.identifier.issue16
dc.identifier.urihttps://hdl.handle.net/20.500.12511/12203
dc.identifier.volume41
dc.identifier.wos001053772005450en_US
dc.identifier.wosqualityQ1
dc.indekslendigikaynakWeb of Science
dc.institutionauthorSevindik, Ömür Gökmen
dc.language.isoen
dc.publisherLippincott Williams & Wilkins
dc.relation.ispartofAnnual Meeting of the American-Society-of-Clinical-Oncology (ASCO)en_US
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectHodgkin Lymphoma
dc.subjectRefractory
dc.subjectChemotherapy
dc.titleKEYFORM-008: Coformulated favezelimab and pembrolizumab (MK4280A) versus chemotherapy in relapsed/refractory classical Hodgkin lymphoma.
dc.typeConference Object

Dosyalar

Lisans paketi
Listeleniyor 1 - 1 / 1
Küçük Resim Yok
İsim:
license.txt
Boyut:
1.44 KB
Biçim:
Item-specific license agreed upon to submission
Açıklama:
İndir

Koleksiyon

Bildiri Koleksiyonu
WoS İndeksli Yayınlar Koleksiyonu